Biomedical data science

Translating multi-omics data into biomedical insight.

Biomedical data analyst with research experience across proteomics, RNA-seq, whole-exome sequencing, machine learning, and clinical phenotype interpretation.

Evidence profile

Built on bioinformatics research, pharmacy training, and international scientific experience.

May brings research experience in Spain, Taiwan, and Thailand across proteomics, RNA-seq, whole-exome sequencing, and cancer-focused biomedical analysis.

4.00/4.00
MSc GPA
Biomedical Sciences, Prince of Songkla University
4
Research countries
Spain, Taiwan, Thailand, Myanmar
2
Poster awards
Cancer/proteomics research presentations
1
Peer-reviewed publication
Anticancer Research, 2021
Scientific focus

A profile across omics, statistics, and biomedical interpretation.

Her work connects OLINK and LC-MS/MS proteomics, RNA-seq, whole-exome sequencing, statistical modeling, and wet-lab context to interpret disease mechanisms and candidate biomarkers.

01

Proteomics: OLINK and LC-MS/MS

02

Transcriptomics and RNA-seq analysis

03

Whole-exome sequencing workflows

04

Machine learning for disease classification

05

Biomarker discovery and pathway interpretation

06

Wet-lab and computational result integration

Experience

From regulatory pharmacy to biomedical data science.

Her experience spans clinical proteomic data integration in Spain, cancer transcriptomics at National Taiwan University, pharmacogenomics research in Thailand, and regulatory pharmacy work in Myanmar.

Feb 2024 - Mar 2025
Spain

Data Analyst Bioinformatician

Institute for Health Science Research Germans Trias i Pujol · Proteomics, clinical phenotypes, cancer and inflammatory disease

  • Integrated OLINK proteomic data with clinical phenotypes to investigate stress-related signaling pathways.
  • Developed and validated Random Forest and linear mixed models in R and Python to classify disease states with over 85% accuracy.
  • Identified immune and oxidative-stress signatures linked to disease resolution and progression.
  • Prepared publication-quality figures and co-authored manuscripts for peer-reviewed journals.
Sep 2022 - Sep 2023
Taiwan

Research Assistant

Department of Internal Medicine, National Taiwan University · RNA sequencing and cancer progression

  • Analyzed transcriptomic changes associated with colorectal and breast cancer progression.
  • Applied Bioconductor workflows including limma, edgeR, PCA, and heatmaps.
  • Collaborated with wet-lab researchers to connect transcriptomic findings with molecular phenotypes.
Jun 2021 - Jul 2022
Thailand

Research Assistant

Faculty of Medicine, Chiang Mai University · Pharmacogenomics and whole-exome sequencing

  • Developed and standardized a pharmacogene panel for osteosarcoma patients.
  • Implemented Linux and R pipelines for variant calling and annotation with GATK, BWA, ANNOVAR, and VEP.
  • Mapped pathways and annotations for downstream genotyping and clinical PK interpretation.
Jan 2015 - Dec 2017
Myanmar

Regulatory Pharmacist

Food and Drug Administration · Regulatory review, pharmacovigilance, and drug quality control

  • Reviewed dossiers and participated in pharmacovigilance activities.
  • Performed Minilab quality-control work for MARC projects following WHO guidelines.
Research validation

Publication, awards, and academic recognition.

Her record includes a peer-reviewed Anticancer Research publication, two poster awards connected to cancer proteomics, and a fully funded OHEC Thailand Scholarship for her master degree.

Publication

Peer-reviewed cancer proteomics research

Serum Proteomic Profiling Reveals Differentially Expressed IGHG3 and A1AG1 as Potential Predictors of Chemotherapeutic Response in Advanced Non-small Cell Lung Cancer

Mon MM, Srisomsap C, Chokchaichamnankit D, Watcharatanyatip K, Weeraphan C, Svasti J, et al. Anticancer Research. 2021;41(4):1871.

Peer-reviewed publication listed in her CV.

May Myat Mon receiving the Poster Presentation Award in 2019
Best Poster Presentation, academic research recognition.
May Myat Mon receiving an award at the Current Drug Development conference in 2020
Conference award recognition connected to cancer proteomics research.
Full OHEC Thailand Scholarship for Master Degree, covering tuition, stipend, health insurance, relocation, and research expenses.
Best Poster Award at the 6th Current Drug Development conference for serum proteomic profiling in non-small cell lung cancer.
Best Poster Presentation of Academic Research at the 35th Annual Conference, Prince of Songkla University.
Technical capability

Methods that connect data, biology, and clinical meaning.

Her technical toolkit includes Python, R, Linux, Random Forest, linear mixed models, SVM, Bioconductor workflows, GATK, BWA, ANNOVAR, VEP, pathway enrichment, and molecular biology methods.

Computational precision medicine

PythonRLinuxlarge-scale data processingmulti-omics integrationclinical phenotype interpretation

Statistics and machine learning

Random Forestlinear mixed modelsSVMfeature selectioncross-validationstatistical modeling

Bioinformatics and omics

OLINKLC-MS/MSRNA-seqwhole-exome sequencinglimmaedgeRGATKBWAANNOVARVEP

Translational research

DNA/RNA extractionqRT-PCRWestern blotwet-lab/computational integrationpathway enrichment
Education

Biomedical sciences and pharmacy foundations.

Her academic path combines an ongoing PhD in Bioinformatics in Spain, a 4.00/4.00 MSc in Biomedical Sciences in Thailand, and a Bachelor of Pharmacy from Myanmar.

Sep 2025 - Present

PhD in Bioinformatics

Universitat Oberta de Catalunya, Spain

Ongoing doctoral research in bioinformatics

2018 - 2020

Master of Science in Biomedical Sciences

Prince of Songkla University, Thailand

GPA: 4.00/4.00

2007 - 2011

Bachelor of Pharmacy

University of Pharmacy, Yangon, Myanmar

Pharmacy foundation for biomedical and regulatory work